You are here: Industry Insights > combination therapy

News List

Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part Two) Xiaomichong
July 09, 2024
In recent years, with the deepening of research into the pathogenesis of myelodysplastic syndromes (MDS), many novel drugs have emerged.
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia PRNewswire
February 27, 2020
Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital of Nanchang.
NICE approves Keytruda combination therapy for NSCLC through CDF pharmaceutical-technology
August 09, 2019
The UK’s healthcare regulator the National Institute of Health and Care Excellence (NICE) has recommended Merck’s Keytruda (pembrolizumab) combined with two chemotherapy drugs ...
Eisai-Merck combination therapy gets breakthrough status in US pharmaceutical-technology
July 25, 2019
Eisai and Merck have secured breakthrough therapy designation for the combination of their respective drugs, Lenvima and Keytruda.
Of Mice and Men: New Light and Sound Combination Therapy May Treat Alzheimer's biospace
April 22, 2019
While Alzheimer's patients can be treated for symptoms or pain, the disease has no cure, and no current treatment can slow its progression.
I-Mab Biopharma collaborates with Roche for combination therapy biospectrumasia
April 11, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of ……
Combination therapy for coinfection with HIV and leishmaniasis europeanpharmaceuticalreview
January 22, 2019
A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis…
Bristol-Myers and Vedanta to study combination therapy for cancer pharmaceutical-technology
December 12, 2018
Bristol-Myers Squibb has partnered with PureTech Health subsidiary Vedanta Biosciences to study its Opdivo in combination with VE800 drug candidate for the treatment of advanced or metastatic cancers.
Invectys raises €15M series A to fund DNA cancer vaccine study in CLL fiercepharma
November 09, 2018
French startup Invectys hopes its cancer vaccine can win a spot in immuno-oncology combination therapies, and it just nabbed €15 million ($17 million) in series A funding to...
Calithera compound empowers immuno-oncology therapies by targeting metabolic signals fiercebiotech
November 02, 2018
Can targeting one metabolic signaling pathway have completely opposite effects on different subsets of T cells? In the case of glutamine metabolism, the answer seems to be ...

Previous page 1 2 Next page